< Back to scientific publications

Magazine 7.4

Management of HCV infection in the penitentiary setting in the direct-acting antivirals era: practical recommendations from an expert panel.

Authors: ranieri r et al

Date: Apr 17, 2023

Scope of interest: infectious diseases/pen health




You may also be interested in:

Report/Poster of Convention/Congress Act

Use of functional magnetic resonance imaging (fMRI) in the study of epilepsy: haemodynamic correlates during spike and polypointer disease in a patient with Juvenile Myoclonic Epilepsy

Authors: M Fanella, AE Vaudano, M Manfredi, AT Giallonardo, A Berardelli , M Carnì, S Casciato, M Morano, L Lapenta, J Fattouch, G Aegean, L Lemieux, C Di Bonaventura

Date: 2012

Scope of interest: Epilepsy


Read details
Report/Poster of Convention/Congress Act

Use of hyperimmune plasma for compassionate use in patients with Marginal Non-Hodgkin Lymphoma persistently positive for SARS-CoV-2 infection

Authors: Cristina D'Amico (1) - Federico De Angelis (1) - Elena Gigliotti (1) - Maria Trimboli (1) - Giorgia Guiducci (1) - Francesca Docimo (1) - Paolo Paesano (1) - Antonietta Arduini (1) - Francesca Chiarlitti (1) - Manuela Alo' (1) - Carla Gargiulo (1)

Date: 2022

Scope of interest: Clinical pathology


Read details
Magazine 9.54

Brivaracetam as add-on treatment in patients with post-stroke epilepsy: real-world data from the BRIVAracetam add-on First ItalianųoRk Study (BRIVAFIRST).

Authors: Lattanzi S, Canafoglia L, Canevini MP, Casciato S, Irelli EC, Chiesa V, Dainese F, De Maria G, Didato G, Gennaro GD, Falcicchio G, Fanella M, Ferlazzo E, Gangitano M, La Neve A, Mecarelli O, Montalenti E, Morano A, Piazza F, Pizzanelli C, Pulitano P, Ranzato F, Rosati E, Tassi L, Di Bonaventura C; BRIVAFIRST Group Membership

Date: 2022

Scope of interest: Epilepsy


Read details